Animal Model Market Size & Share, By Animal Type (Mice, Guinea Pigs), Application (Cancer, Infectious Disease), End-use (CRO, Academic Research Institute), Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Market Outlook:

Animal Model Market exceeded USD 2.27 Billion in 2023 and is predicted to cross USD 4.81 Billion by end of the year 2032, growing at over 8.7% CAGR between 2024 and 2032.

• Base Year Value (2023): USD 2.27 Billion
• CAGR (2024-2032): 8.7%
• Forecast Year Value (2032): USD 4.81 Billion
• Historical Data Period: 2019-2023
• Largest Region: North America
• Forecast Period: 2024-2032

Market Dynamics:

Growth Drivers & Opportunity:

Increasing research and development activities in the pharmaceutical and biotechnology industries are driving the growth of the animal model market. Animal models are crucial for studying diseases, drug discovery, and development, which is fueling the demand for these models.

The rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, is also a major growth driver for the animal model market. Animal models play a crucial role in understanding the disease mechanisms, testing new therapeutics, and evaluating treatment efficacy, thus driving the market growth.

Advancements in genome editing technologies, such as CRISPR-Cas9, are enabling researchers to create more precise and genetically modified animal models for studying various diseases. This technological advancement is boosting the demand for animal models in research and development activities, further driving market growth.

Report Scope

Report Coverage	Details
Segments Covered	Animal Type, Application, End-Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Charles River Laboratories, The Jackson Laboratory, genOway, Taconic Biosciences,, Janvier Labs, Harbour BioMed, Crown Bioscience, Inotiv, BIOCYTOGEN, BioSpherix,.

Industry Restraints:

Stringent regulations and ethical concerns regarding the use of animals in research are major restraints for the animal model market. Regulatory bodies are imposing strict guidelines for the ethical treatment of animals used in research, which can limit the availability and use of animal models in studies.

High costs associated with the maintenance and care of animal models are also a significant restraint for the market. The expenses involved in housing, feeding, and monitoring animals can be substantial, especially for large-scale research projects, which can hinder the adoption of animal models in research activities.

Regional Forecast:

North America:

The Animal Model Market in North America is expected to experience significant growth due to the presence of a well-established healthcare infrastructure, increasing research and development activities, and a growing focus on personalized medicine. The United States holds the largest market share in the region, followed by Canada. The increasing prevalence of chronic diseases and the development of advanced animal models for disease research are driving the market growth in North America.

Asia Pacific:

The Asia Pacific region is expected to witness substantial growth in the Animal Model Market, particularly in countries like China, Japan, and South Korea. The presence of a large number of pharmaceutical and biotechnology companies, along with increasing government funding for research activities, are driving market growth in the region. China is expected to dominate the market in Asia Pacific due to its rapidly expanding research capabilities and lower costs compared to Western countries.

Europe:

Europe, particularly countries like the United Kingdom, Germany, and France, is expected to witness steady growth in the Animal Model Market. The presence of a strong pharmaceutical and biotechnology industry, along with significant investments in research and development, are driving market growth in the region. The United Kingdom, in particular, is a key market for animal models in Europe due to its strong academic and research institutions.

Segmentation Analysis:

In terms of segmentation, the global Animal Model market is analyzed on the basis of Animal Type, Application, End-Use.

Animal Model Market:

Mice:

The segment of the animal model market focused on mice is expected to witness significant growth in the coming years. Mice are one of the most commonly used animal models in research, particularly in the fields of cancer and infectious disease. Their genetic and physiological similarities to humans make them valuable in studying various diseases and testing potential treatments. As a result, the demand for mice in academic research institutes and contract research organizations (CROs) is likely to increase, driving growth in this segment.

Guinea Pigs:

Guinea pigs are another animal type commonly used in the animal model market, particularly in infectious disease research. Their susceptibility to certain pathogens makes them valuable in studying diseases such as tuberculosis and influenza. As the global focus on infectious diseases continues to grow, the demand for guinea pigs in research is expected to rise. Academic research institutes and CROs will likely be key end-users of guinea pigs in this segment.

Cancer:

The application segment of the animal model market focused on cancer research is poised for significant growth in the coming years. Animal models, particularly mice, play a crucial role in studying the mechanisms of cancer and testing potential treatments. With the increasing prevalence of cancer worldwide, the demand for animal models for cancer research is expected to increase. This growth will be driven by both academic research institutes and CROs seeking to develop new therapies and improve existing treatments.

Infectious Disease:

The infectious disease segment of the animal model market is expected to see steady growth in the coming years. Animal models, including mice and guinea pigs, are vital in studying infectious diseases such as HIV, Ebola, and Zika. With the ongoing threat of emerging infectious diseases, the demand for animal models for infectious disease research is likely to increase. Academic research institutes and CROs will continue to rely on animal models to advance our understanding of these diseases and develop effective treatments.

CRO:

The end-use segment of the animal model market focused on CROs is anticipated to experience significant growth in the near future. CROs play a crucial role in conducting preclinical research and drug development on behalf of pharmaceutical companies and biotechnology firms. As the pharmaceutical industry continues to grow and outsource more research activities, the demand for animal models in CROs is expected to increase. This trend will drive growth in the overall animal model market, particularly in segments such as mice and infectious diseases.

Academic Research Institute:

The segment of the animal model market focused on academic research institutes is expected to remain a key player in the coming years. Academic institutions play a vital role in basic research and translational science, utilizing animal models to study a wide range of diseases and develop new treatments. The demand for animal models in academic research institutes is likely to grow as funding for research and collaborations with industry continue to increase. This segment will continue to drive innovation and advancements in the field of animal modeling.

Competitive Landscape:

The animal model market is characterized by a highly competitive landscape with various players vying for a significant share. The market is driven by the increasing demand for preclinical testing and the need for better understanding of human diseases, which in turn fuels innovation and research activities in the sector. Major companies are focusing on development of genetically modified animal models and enhancing their service offerings to meet the diverse requirements of pharmaceutical, biotechnology, and academic research institutions. Key strategies employed by these companies include mergers and acquisitions, partnerships, and collaborations to expand their product portfolio and geographic reach. The growing emphasis on personalized medicine and advanced technologies such as CRISPR are also reshaping the competitive dynamics, propelling startups to emerge alongside established players.

Top Market Players

- Charles River Laboratories

- The Jackson Laboratory

- Taconic Biosciences

- Envigo

- Horizon Discovery Group

- IsoPlexis

- Covance Inc. (Labcorp)

- Syngene International

- Charles River Biopharmaceutical Services

- GenOway